This Year, PBM-Directed Fury May Once Again Signify Nothing

2025 Pink Sheet Perspectives
Industry observers questioned whether the PBM status quo will change, even if reform legislation is enacted. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from PBMs

More from Pink Sheet Perspectives